AHG logo

Akso Health Group (AHG)

For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Akso Health Group (AHG) trades at $2.45 with AI Score 67/100 (Buy). Akso Health Group operates a social e-commerce platform in China, offering a variety of products through its Xiaobai Maimai App. Market cap: 233M, Sector: Financial services.

Last analyzed: Mar 15, 2026
Akso Health Group operates a social e-commerce platform in China, offering a variety of products through its Xiaobai Maimai App. The company also provides consultancy and IT support services, trades in branded products, and promotes products.
67/100 AI Score MCap 233M Vol 137K

Akso Health Group (AHG) Financial Services Profile

CEOYilin Wang
Employees9
HeadquartersQingdao, CN
IPO Year2017

Akso Health Group operates a social e-commerce platform in China, focusing on the Xiaobai Maimai App for diverse consumer products. The company distinguishes itself by offering consultancy and IT support services alongside its e-commerce operations, positioning it within the competitive Chinese financial services sector.

Data Provenance | Financial Data Quantitative Analysis NASDAQ Analysis: Mar 15, 2026

Investment Thesis

Akso Health Group presents a high-risk, high-reward investment profile. The company's negative profit margin of -1190.8% and gross margin of -3.3% raise concerns about its financial sustainability. With a market capitalization of $0.24 billion and a negative P/E ratio of -6.17, valuation is speculative. Growth catalysts include expanding its product offerings and leveraging its social e-commerce platform. However, investors should carefully consider the risks associated with its financial performance and competitive landscape. The company's beta of -0.66 suggests a lower volatility compared to the market.

Based on FMP financials and quantitative analysis

Key Highlights

  • Market capitalization of $0.24 billion reflects its current valuation in the financial market as of March 15, 2026.
  • Negative P/E ratio of -6.17 indicates the company is currently not profitable.
  • Profit margin of -1190.8% highlights significant challenges in achieving profitability.
  • Gross margin of -3.3% suggests difficulties in managing the cost of goods sold.
  • Beta of -0.66 indicates a lower volatility compared to the market.

Competitors & Peers

Strengths

  • Established social e-commerce platform.
  • Diverse product offerings.
  • Provision of consultancy and IT support services.
  • Subsidiary of Webao Limited.

Weaknesses

  • Negative profit margin.
  • Low gross margin.
  • Limited brand recognition compared to larger e-commerce platforms.
  • Small number of employees.

Catalysts

  • Upcoming: Expansion of product categories on the Xiaobai Maimai App to attract new customers and increase sales.
  • Ongoing: Enhanced user engagement through personalized recommendations and loyalty programs to improve customer retention.
  • Upcoming: Strategic partnerships with established brands and suppliers to enhance product offerings and supply chain efficiency.
  • Ongoing: Geographic expansion within China to tap into underserved markets and increase its customer base.
  • Ongoing: Investment in advanced technologies such as AI and machine learning to improve operational efficiency and customer experience.

Risks

  • Ongoing: Intense competition in the Chinese e-commerce market from established players and emerging platforms.
  • Potential: Changing consumer preferences and the need to adapt to evolving trends in online shopping.
  • Potential: Regulatory changes in China that could impact the company's operations and financial performance.
  • Potential: Economic slowdown in China that could reduce consumer spending and impact sales.
  • Ongoing: Negative profit margin and low gross margin, raising concerns about financial sustainability.

Growth Opportunities

  • Expansion of Product Categories: Akso Health Group can drive growth by expanding its product categories on the Xiaobai Maimai App. Focusing on high-margin products and catering to niche markets can improve profitability. The e-commerce market in China is projected to reach trillions of dollars by 2028, offering a substantial opportunity for growth. Timeline: Ongoing.
  • Enhanced User Engagement: Improving user engagement through personalized recommendations, loyalty programs, and interactive social features can increase customer retention and drive sales. Leveraging data analytics to understand user behavior and preferences is crucial. The social commerce market is expected to grow significantly, providing a favorable environment. Timeline: Ongoing.
  • Strategic Partnerships: Forming strategic partnerships with established brands and suppliers can enhance product offerings and improve supply chain efficiency. Collaborating with key influencers and content creators can also boost brand awareness and drive traffic to the platform. This can lead to increased sales and market share. Timeline: Within the next 12-18 months.
  • Geographic Expansion: Expanding its operations to new regions within China can tap into underserved markets and increase its customer base. Adapting its product offerings and marketing strategies to local preferences is essential for success. The Chinese e-commerce market is vast and diverse, offering ample opportunities for geographic expansion. Timeline: Within the next 24-36 months.
  • Leveraging Technology: Investing in advanced technologies such as artificial intelligence and machine learning can improve operational efficiency, personalize customer experiences, and enhance fraud detection. Implementing blockchain technology can also improve supply chain transparency and build trust with customers. Timeline: Ongoing.

Opportunities

  • Expansion of product categories.
  • Enhanced user engagement.
  • Strategic partnerships.
  • Geographic expansion within China.

Threats

  • Intense competition in the Chinese e-commerce market.
  • Changing consumer preferences.
  • Regulatory changes.
  • Economic slowdown in China.

Competitive Advantages

  • Established social e-commerce platform in China.
  • Diverse product offerings on the Xiaobai Maimai App.
  • Provision of consultancy and IT support services.
  • Subsidiary of Webao Limited, providing financial backing and resources.

About AHG

Akso Health Group, formerly known as Xiaobai Maimai Inc., was founded in 2014 and rebranded in December 2021. Headquartered in Beijing, China, the company operates a social e-commerce mobile platform, primarily through its Xiaobai Maimai App. This platform offers a wide array of products, including food and beverage items, wine, cosmetics, fashion and apparel, entertainment products, housewares, and home appliances. In addition to its e-commerce activities, Akso Health Group provides consultancy and information technology support services. The company also engages in trading branded products and promoting various goods. As of July 13, 2021, Akso Health Group functions as a subsidiary of Webao Limited. The company aims to leverage social commerce trends in the Chinese market to connect consumers with a diverse product range and supplementary services.

What They Do

  • Operates a social e-commerce mobile platform in China.
  • Offers a variety of products through the Xiaobai Maimai App, including food, beverages, cosmetics, and apparel.
  • Provides consultancy and IT support services.
  • Trades in branded products.
  • Promotes products through its platform.
  • Functions as a subsidiary of Webao Limited.

Business Model

  • Generates revenue through the sale of products on its Xiaobai Maimai App.
  • Earns fees from consultancy and IT support services.
  • Profits from trading branded products.
  • Revenue from advertising and promotion services on its platform.

Industry Context

Akso Health Group operates within the competitive Chinese financial services sector, specifically in the realm of social e-commerce. This market is characterized by rapid growth, driven by increasing internet penetration and consumer adoption of online shopping. The company faces competition from established e-commerce giants and emerging fintech platforms. Success in this environment requires effective marketing, strong customer engagement, and the ability to adapt to evolving consumer preferences and regulatory changes.

Key Customers

  • Consumers in China who use mobile devices for online shopping.
  • Businesses seeking consultancy and IT support services.
  • Brands looking to promote their products on the Xiaobai Maimai App.
  • Users of social e-commerce platforms.
AI Confidence: 71% Updated: Mar 15, 2026

Financials

Chart & Info

Akso Health Group (AHG) stock price: $2.45 (-0.05, -2.00%)

Latest News

Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for AHG.

Price Targets

Wall Street price target analysis for AHG.

MoonshotScore

67/100

What does this score mean?

The MoonshotScore rates AHG's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.

Leadership: Yilin Wang

CEO

Yilin Wang serves as the CEO of Akso Health Group, leading a team of 9 employees. Information regarding Yilin Wang's detailed career history, educational background, and previous roles is not available in the provided data. However, as CEO, Yilin Wang is responsible for the overall strategic direction and operational management of the company.

Track Record: Due to limited information, specific achievements and milestones under Yilin Wang's leadership cannot be detailed. However, the CEO's role is crucial in navigating the competitive Chinese e-commerce market and driving the company's growth strategy.

Akso Health Group ADR Information Sponsored

An American Depositary Receipt (ADR) is a certificate representing shares of a foreign company that trades on U.S. stock exchanges. AHG, as an ADR, allows U.S. investors to invest in Akso Health Group, a Chinese company, without the complexities of cross-border transactions. The ADR is denominated in U.S. dollars and trades during U.S. market hours.

  • Home Market Ticker: Primary stock exchange is in China, with headquarters in Qingdao.
  • ADR Level: 2
  • ADR Ratio: 1:1
Currency Risk: Investing in AHG as an ADR exposes U.S. investors to currency risk. The value of the ADR can fluctuate based on changes in the exchange rate between the U.S. dollar and the Chinese Yuan. If the Yuan depreciates against the dollar, the value of the ADR may decrease, even if the underlying stock price in China remains stable.
Tax Implications: Dividends paid on AHG's ADR may be subject to foreign dividend withholding tax in China. The standard withholding tax rate is typically around 10%, but this can vary based on tax treaties between the U.S. and China. U.S. investors may be able to claim a foreign tax credit on their U.S. tax return for the amount of foreign tax withheld.
Trading Hours: The trading hours for AHG's underlying shares in China differ significantly from U.S. trading hours. This can create opportunities and risks for ADR holders, as news and events occurring during Chinese trading hours may not be immediately reflected in the ADR price until the U.S. market opens. Investors should be aware of this time difference and its potential impact on trading decisions.

Common Questions About AHG

What does Akso Health Group do?

Akso Health Group operates a social e-commerce platform in China through its Xiaobai Maimai App. The company offers a diverse range of products, including food, beverages, cosmetics, apparel, housewares, and home appliances. In addition to its e-commerce activities, Akso Health Group provides consultancy and IT support services. The company generates revenue through product sales, service fees, and advertising on its platform, targeting consumers in China who use mobile devices for online shopping.

What do analysts say about AHG stock?

Analyst coverage of Akso Health Group (AHG) is limited. Key valuation metrics such as the negative P/E ratio of -6.17 and a profit margin of -1190.8% suggest significant financial challenges. Growth considerations include the company's ability to expand its product offerings, enhance user engagement, and form strategic partnerships. Investors should conduct thorough due diligence and consider the risks associated with its financial performance and competitive landscape before investing.

What are the main risks for AHG?

Akso Health Group faces several key risks. Intense competition in the Chinese e-commerce market from established players poses a significant challenge. Changing consumer preferences and regulatory changes in China could also impact the company's operations. Additionally, the company's negative profit margin and low gross margin raise concerns about its financial sustainability. An economic slowdown in China could further reduce consumer spending and impact sales.

What are the key factors to evaluate for AHG?

Akso Health Group (AHG) currently holds an AI score of 67/100, indicating moderate score. Key strength: Established social e-commerce platform.. Primary risk to monitor: Ongoing: Intense competition in the Chinese e-commerce market from established players and emerging platforms.. This is not financial advice.

How frequently does AHG data refresh on this page?

AHG prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.

What has driven AHG's recent stock price performance?

Recent price movement in Akso Health Group (AHG) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Established social e-commerce platform.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.

Should investors consider AHG overvalued or undervalued right now?

Determining whether Akso Health Group (AHG) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.

What research should beginners do before buying AHG?

Before investing in Akso Health Group (AHG), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Analysis updated AI Score refreshed daily
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .

Data provided for informational purposes only.

Analysis Notes
  • Information is based on available data as of March 15, 2026.
  • Financial data may be subject to change.
  • Analyst opinions may vary.
Data Sources

Popular Stocks